Active, not recruitingNot applicableNCT04562558
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia
Studying Gestational choriocarcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- xiang yang
- Principal Investigator
- yang xiangPeking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences
- Intervention
- Methotrexate(drug)
- Enrollment
- 228 enrolled
- Eligibility
- 18-75 years · FEMALE
- Timeline
- 2020 – 2025
Study locations (1)
- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04562558 on ClinicalTrials.gov